Mexico Hyperglycemics Research
10 comprehensive market analysis studies and research reports on the Mexico Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 84 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Middle East And Africa Human Insulin Market
CAGR: 3.78%
Study Period : 2019 - 2030
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.61%
Study Period : 2019 - 2030
North America Human Insulin Drugs Market
CAGR: 3.91%
Study Period : 2019 - 2030
Asia - Pacific Human Insulin Market
CAGR: 2.54%
Study Period : 2019 - 2030
North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market
CAGR: 8.67%
Study Period : 2019 - 2030
Healthcare
Categories
10 Healthcare Reports
Categories
Showing 10 of 10 results in Hyperglycemics
Insulin Market
CAGR: 3.87%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Novo Nordisk, Eli Lilly and Company, Pfizer, Sanofi, Biocon Biologics
SGLT2 Inhibitor Market
CAGR: 8.68%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Janssen, Boehringer Ingelheim, Eli Lilly and Company, Astellas Pharma, AstraZeneca
Latin America Meglitinide Market
CAGR: 3.30%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, KISSEI PHARMACEUTICAL, Novartis, Biocon
TRENDING REPORTS
Middle East And Africa Human Insulin Market
CAGR: 3.78%
Study Period : 2019 - 2030
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.61%
Study Period : 2019 - 2030
North America Human Insulin Drugs Market
CAGR: 3.91%
Study Period : 2019 - 2030
Asia - Pacific Human Insulin Market
CAGR: 2.54%
Study Period : 2019 - 2030
North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market
CAGR: 8.67%
Study Period : 2019 - 2030
Latin America Human Insulin Drugs Market
CAGR: 3.10%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Pfizer
Latin America Biguanide Market
CAGR: 2.80%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Bristol-Myers Squibb, Boehringer Ingelheim, Merck, Sanofi, Glenmark Pharmaceuticals
Insulin Glargine Market
CAGR: 6.28%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar
Basal Insulin Market
CAGR: 4.70%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Biguanides Market
CAGR: 2.34%
Study Period: 2019 - 2030
Country Covered: Mexico
Major Players:Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
